Interestingly, H19 has been described to play a role in obesity-induced cancer and to promote epithelial-mesenchymal transition of CRC, with a reported poor prognosis for cancer patients exhibiting H19 induction (73, 74). Here, H19 is linked to obesity due to melanocortin 4 receptor deficiency.